Lexicon to Report Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
February 20 2008 - 4:00PM
PR Newswire (US)
Conference Call and Webcast to Follow THE WOODLANDS, Texas, Feb. 20
/PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc.
(NASDAQ:LXRX) will release its fourth quarter and year end 2007
financial results on Thursday, March 6, 2008 after the financial
markets close. Lexicon management will hold a conference call to
discuss its clinical development progress, financial results for
2007 and financial guidance for 2008 at 5:00 p.m. Eastern Time on
March 6, 2008. The dial-in number for the conference call is
877-681-3378 (within the United States) or 719-325-4842
(international). The pass code for all callers is 7721341.
Investors can access a live webcast of the call at
http://www.lexpharma.com/. An archived version of the webcast will
be available on the website through March 11, 2008. About Lexicon
Lexicon is a biopharmaceutical company focused on the discovery and
development of breakthrough treatments for human disease. Lexicon
currently has development programs underway for such areas of major
unmet medical need as irritable bowel syndrome, cognitive
disorders, autoimmune diseases, and carcinoid syndrome. The company
has used its proprietary gene knockout technology to discover more
than 100 promising drug targets and create an extensive pipeline of
clinical and preclinical programs in the therapeutic areas of
cardiology, gastroenterology, immunology and oncology, metabolism,
neurology and ophthalmology. To advance the development and
commercialization of its programs, Lexicon is working both
independently and through collaborators including Bristol-Myers
Squibb Co., Genentech, Inc. and N.V. Organon. For additional
information about Lexicon and its programs, please visit
http://www.lexpharma.com/. Safe Harbor Statement This press release
contains "forward-looking statements," including statements
relating to Lexicon's growth and future operating results,
discovery and development of products, strategic alliances and
intellectual property, as well as other matters that are not
historical facts or information. All forward-looking statements are
based on management's current assumptions and expectations and
involve risks, uncertainties and other important factors that may
cause Lexicon's actual results to be materially different from any
future results expressed or implied by such forward-looking
statements. Information identifying such important factors is
contained under "Factors Affecting Forward-Looking Statements" and
"Risk Factors" in Lexicon's annual report on Form 10-K for the year
ended December 31, 2006, as filed with the Securities and Exchange
Commission. Lexicon undertakes no obligation to update or revise
any such forward-looking statements, whether as a result of new
information, future events or otherwise. DATASOURCE: Lexicon
Pharmaceuticals, Inc. CONTACT: Bobbie Faulkner, Manager, Investor
and Public Relations of Lexicon, +1-281-863-3503, Web site:
http://www.lexpharma.com/
Copyright
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jul 2023 to Jul 2024